Resmed has named Salli Schwartz as chief investor relations officer, where she will lead the company’s global investor relations function and report to Mick Farrell, chairman of the board ...

Greetings, and welcome to the Q3 fiscal year 2025 ResMed earnings conference call. My name is Kevin, and I'll be your operator for today's call. (Operator Instructions) And also, please note this ...

KeyBanc analyst Brett Fishbin raised the firm’s price target on ResMed (RMD) to $274 from $269 on higher estimates, while keeping an Overweight ...

KeyBanc analyst Brett Fishbin maintained a Buy rating on Resmed (RMD – Research Report) today. The company’s shares closed yesterday at ...